Akira Morimiya

1.4k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Akira Morimiya is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Akira Morimiya has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Akira Morimiya's work include Estrogen and related hormone effects (6 papers), Cancer Cells and Metastasis (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Akira Morimiya is often cited by papers focused on Estrogen and related hormone effects (6 papers), Cancer Cells and Metastasis (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Akira Morimiya collaborates with scholars based in United States, Canada and Malaysia. Akira Morimiya's co-authors include Sunil Badve, Harikrishna Nakshatri, Poornima Bhat‐Nakshatri, Susan E. Clare, Hui Lin Chua, Mangesh A. Thorat, Sanjana Mehrotra, Beamon Agarwal, Dmitry Turbin and Raymond L. Konger and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Akira Morimiya

16 papers receiving 1.1k citations

Hit Papers

NF-κB represses E-cadherin expression and enhances epithe... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akira Morimiya United States 11 628 504 343 190 159 16 1.1k
Elizabeth Bruckheimer United States 19 587 0.9× 475 0.9× 300 0.9× 162 0.9× 290 1.8× 32 1.2k
Cheng‐Chi Chang Taiwan 21 1.3k 2.1× 502 1.0× 478 1.4× 113 0.6× 110 0.7× 26 1.8k
Mei‐Ren Pan Taiwan 27 1.3k 2.0× 691 1.4× 410 1.2× 164 0.9× 98 0.6× 58 1.9k
Earl Lawrence United States 12 733 1.2× 320 0.6× 257 0.7× 164 0.9× 135 0.8× 14 1.5k
Georgia Sotiropoulou‐Bonikou Greece 16 445 0.7× 252 0.5× 210 0.6× 324 1.7× 109 0.7× 36 973
Scott Wise United States 17 660 1.1× 293 0.6× 161 0.5× 157 0.8× 179 1.1× 43 1.2k
Anna‐Mária Tõkés Hungary 19 480 0.8× 360 0.7× 380 1.1× 67 0.4× 135 0.8× 92 1.3k
Farzaneh Pirnia United States 12 805 1.3× 507 1.0× 248 0.7× 74 0.4× 177 1.1× 14 1.2k
W K Hong United States 14 745 1.2× 285 0.6× 199 0.6× 431 2.3× 131 0.8× 18 1.2k
Roberto E. Favoni Italy 20 844 1.3× 541 1.1× 327 1.0× 291 1.5× 356 2.2× 39 1.6k

Countries citing papers authored by Akira Morimiya

Since Specialization
Citations

This map shows the geographic impact of Akira Morimiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Morimiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Morimiya more than expected).

Fields of papers citing papers by Akira Morimiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Morimiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Morimiya. The network helps show where Akira Morimiya may publish in the future.

Co-authorship network of co-authors of Akira Morimiya

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Morimiya. A scholar is included among the top collaborators of Akira Morimiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Morimiya. Akira Morimiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hammoud, Zane T., Sunil Badve, Qianqian Zhao, et al.. (2009). Differential gene expression profiling of esophageal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 137(4). 829–834. 10 indexed citations
2.
Duchnowska, Renata, Jacek Jassem, Mangesh A. Thorat, et al.. (2009). Molecular characteristics of matched brain metastasis (BM) versus the primary breast cancer (PBC).. Cancer Research. 69(2_Supplement). 2028–2028. 1 indexed citations
3.
Thorat, Mangesh A., Sanjana Mehrotra, Akira Morimiya, & Sunil Badve. (2009). COX-2 Expression Does Not Correlate with Microvessel Density in Breast Cancer. Pathobiology. 76(1). 39–44. 6 indexed citations
4.
Thorat, Mangesh A., Dmitry Turbin, Akira Morimiya, et al.. (2008). Amplified in breast cancer 1 expression in breast cancer. Histopathology. 53(6). 634–641. 9 indexed citations
5.
Duchnowska, Renata, Jacek Jassem, Mangesh A. Thorat, et al.. (2008). Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts). Journal of Clinical Oncology. 26(15_suppl). 1019–1019. 7 indexed citations
6.
Thorat, Mangesh A., Akira Morimiya, Sanjana Mehrotra, Raymond L. Konger, & Sunil Badve. (2007). Prostanoid receptor EP1 expression in breast cancer. Modern Pathology. 21(1). 15–21. 25 indexed citations
7.
Thorat, Mangesh A., Caterina Marchiò, Akira Morimiya, et al.. (2007). Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. Journal of Clinical Pathology. 61(3). 327–332. 97 indexed citations
8.
Badve, Sunil, et al.. (2007). Apoptosis in spermatocytic and usual seminomas: a light microscopic and immunohistochemical study. Modern Pathology. 20(10). 1036–1044. 11 indexed citations
9.
Badve, Sunil, Dmitry Turbin, Mangesh A. Thorat, et al.. (2007). FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival. Clinical Cancer Research. 13(15). 4415–4421. 196 indexed citations
10.
Chua, Hui Lin, Poornima Bhat‐Nakshatri, Susan E. Clare, et al.. (2006). NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene. 26(5). 711–724. 507 indexed citations breakdown →
11.
Badve, Sunil, Dmitry Turbin, Akira Morimiya, et al.. (2006). Prediction of long-term survival using expression of FOXA1, a determinant of estrogen response domains in breast cancer. Journal of Clinical Oncology. 24(18_suppl). 539–539. 1 indexed citations
12.
Fomin, Victor P., Shawn G. Gibbs, Ram Vanam, Akira Morimiya, & William W. Hurd. (2006). Effect of magnesium sulfate on contractile force and intracellular calcium concentration in pregnant human myometrium. American Journal of Obstetrics and Gynecology. 194(5). 1384–1390. 35 indexed citations
13.
Agarwal, Beamon, Romil Saxena, Akira Morimiya, Sanjana Mehrotra, & Sunil Badve. (2005). Lymphangiogenesis Does Not Occur in Breast Cancer. The American Journal of Surgical Pathology. 29(11). 1449–1455. 71 indexed citations
14.
Konger, Raymond L., Steven D. Billings, Akira Morimiya, et al.. (2005). Immunolocalization of Low-Affinity Prostaglandin E2 Receptors, EP1 and EP2, in Adult Human Epidermis. Journal of Investigative Dermatology. 124(5). 965–970. 32 indexed citations
15.
Mehrotra, Sanjana, Akira Morimiya, Beamon Agarwal, Raymond L. Konger, & Sunil Badve. (2005). Microsomal prostaglandin E2 synthase‐1 in breast cancer: a potential target for therapy. The Journal of Pathology. 208(3). 356–363. 70 indexed citations
16.
Bhat‐Nakshatri, Poornima, Hiromitsu Kishimoto, Robert J. Goulet, et al.. (2005). The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis. 26(5). 900–907. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026